Back to Journals » Neuropsychiatric Disease and Treatment » Volume 17

Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease [Corrigendum]

Authors Zhang M, Han W, Xu Y, Li D, Xue Q

Received 10 February 2021

Accepted for publication 10 February 2021

Published 16 February 2021 Volume 2021:17 Pages 513—514

DOI https://doi.org/10.2147/NDT.S306151


Zhang M, Han W, Xu Y, Li D, Xue Q. Neuropsychiatr Dis Treat. 2021;17:269–275.

The authors have advised there is an error in the author list on page 269. The author name “Ming Zhang” should read “Min Zhang”.

The authors apologize for this error


Read the original article

Zhang M, Han W, Xu Y, Li D, Xue Q. Neuropsychiatr Dis Treat. 2021;17:269–275.

The authors have advised there is an error in the author list on page 269. The author name “Ming Zhang” should read “Min Zhang”.

The authors apologize for this error.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]